tiprankstipranks
Sientra price target lowered to $5 from $7 at Maxim
The Fly

Sientra price target lowered to $5 from $7 at Maxim

Maxim analyst Anthony Vendetti lowered the firm’s price target on Sientra to $5 from $7 but keeps a Buy rating on the shares. The analyst cites the company Q4 revenue, gross margin, and earnings coming in below consensus and the firm’s forecast, even though the gross margin included non-cash expenses related to inventory reserves and warranty liability that kept it from topping its estimates. Maxim adds that despite the slight revenue miss, it is encouraged by the continued market share gains in the breast market, the addition of roughly 275 new accounts during the quarter, and the potential of the recently launched Viality fat grafting device.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on SIEN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles